Drawing for JAD

USPTO serial 75779578

JAD

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
COWARD, JEFFERY
Law office
FILE REPOSITORY (FRANCONIA)

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with JAD?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

JESUS SANCHELIMA

JESUS SANCHELIMA SANCHELIMA & ASSOCIATES PA235 SW LE JEUNE RDMIAMI, FL 33134UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
003cosmetics, fragrances, and accessories, namely, lipsticks, eye shadow pencils, nail polish, skin and body creams, hair shampoos and conditioners, personal deodorants, suntan lotions, petroleum jelly for cosmetics purposes, mouthwash, body sprays, body oils and fragrances, namely, perfumes, colognes, and aftershave, skin and body soaps, anti-bacterial hand soaps, toothpastes, hair styling gel and sprays, hand/skin moisturizers, hair loss control shampoos, shower and bath gel, lip liners, lip sealers, lip gloss, nail hardener, nail polish remover, eye makeup, hair color and dyes, creams for cellulite reduction, shaving creams and gels, body lotions, hair removal creams, depilatory wax creams and strips, and baby products and accessories, namely, baby wipes, skin and body creams, body oils, baby hair shampoos and conditioners, and baby powder, all marketed and distributed through retail channelsACTIVE—
005pharmaceutical products, namely, vaccines, antibiotic ointments, surgical dressings, analgesics, preparations for treating coughs and colds, eye care products, namely, washes, drops, and contact lens cleaning and disinfecting solutions, first aid kits, vitamins, nutritional and mineral supplements, herbal supplements, inhalers containing allergy and asthma relief medications, gastro-intestinal treatment preparations and allergy relief medications, isopropyl alcohol for topical use, hydrogen peroxide for medical use, pregnancy test kits for home use, and adult diapersACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (ABN6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Sep 12, 2001ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Feb 12, 2001EX1GSOU EXTENSION 1 GRANTED—
Dec 22, 2000EXT1SOU EXTENSION 1 FILED—
Jun 27, 2000NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 4, 2000PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 3, 2000NPUBNOTICE OF PUBLICATION—
Feb 9, 2000CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 2, 2000CNEAEXAMINER'S AMENDMENT MAILED—
Dec 29, 1999DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance